• 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け

特許

68,018 件
全IP種別
PATENTFIELDで検索
IPを掲載
権利維持

Lubricant

A lubricant is a substance introduced to reduce friction between surfaces in mutual contact, which ultimately reduces the heat generated when the surfaces move. It may also have the function of tra...

係属中

Detecting organisms using s...

Detecting organisms using stochastic confinement

権利維持

Liver X receptor agonists

LXR agonists are effective for treatment of murine models of atherosclerosis, diabetes, anti-inflammation, and Alzheimer's disease. Treatment with LXR agonists (hypocholamide, T0901317, GW3965, or ...

係属中

Assaying blood clotting

Coagulation (clotting) is the process by which blood changes from a liquid to a gel. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The...

係属中

Electrolytic production of ...

The conversion of alumina to aluminum metal is achieved by the Hall-Héroult process. In this energy-intensive process, a solution of alumina in a molten (950 and 980 °C (1,740 and 1,800 °F)) mixtur...

係属中

Reducing cell death

Cell death is the event of a biological cell ceasing to carry out its functions. This may be the result of the natural process of old cells dying and being replaced by new ones, or may result from ...

権利維持

NKT cell

Natural killer T (NKT) cells are a heterogeneous group of T cells that share properties of both T cells and natural killer (NK) cells. Many of these cells recognize the non-polymorphic CD1d molecul...

権利維持

Hypothermia

Hypothermia (from Greek ὑποθερμία) is a condition in which the body's core temperature drops below that required for normal metabolism and body functions. This is generally considered to be less th...

権利維持

Plants modified with mini-c...

In 2006, scientists demonstrated the successful use of telomere truncation in maize plants to produce minichromosomes that could be utilized as a platform for inserting genes into the plant genome[...

係属中

Engineered herpes simplex v...

Engineered herpes simplex virus

係属中

APOA1

Apolipoprotein A-I is a protein that in humans is encoded by the APOA1 gene.[1][2] It has a specific role in lipid metabolism. Recent report suggest that APOA1 mRNA is regulated by endogenously exp...

係属中

Myelination disorders

A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged.[1] This damage impairs the conduction of signals in the affected nerves. In turn, the ...

権利維持

Optical fractionation

Optical fractionation

係属中

CHI3L1

Chitinase-3-like protein 1 (CHI3L1), also known as YKL-40, is a secreted glycoprotein that is approximately 40kDa in size that in humans is encoded by the CHI3L1 gene.[1][2][3] The name YKL-40 is d...

権利維持

Immune suppression

Immunosuppression involves an act that reduces the activation or efficacy of the immune system. Some portions of the immune system itself have immuno-suppressive effects on other parts of the immun...

係属中

Therapeutic delivery

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.[1] It ...

権利維持

Lithium batteries

Lithium batteries are disposable (primary) batteries that have lithium metal or lithium compounds as an anode. They stand apart from other batteries in their high charge density (long life) and hig...

係属中

Blots

A blot, in molecular biology and genetics, is a method of transferring proteins, DNA or RNA, onto a carrier (for example, a nitrocellulose PVDF or nylon membrane). In many instances, this is done a...

係属中

HLA-G

HLA-G histocompatibility antigen, class I, G, also known as human leukocyte antigen G (HLA-G), is a protein that in humans is encoded by the HLA-G gene.[1] HLA-G belongs to the HLA nonclassical ...

係属中

Receptor mediated delivery ...

Receptor mediated delivery of agents

  • 最初
  • 前
  • …
  • 1761
  • 1762
  • 1763
  • 1764
  • 1765
  • 1766
  • 1767
  • 1768
  • 1769
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

© 2026 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム